Nephros (NEPH) Revenue Growth (1y) (2011 - 2026)
Nephros (NEPH) Revenue Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 124.86 Bn | 119.64 Bn | 1.96 Bn | 18.54% |
| 2 | Becton Dickinson | 44.42 Bn | 43.60 Bn | 2.15 Bn | 5.22% |
| 3 | Alcon | 33.14 Bn | 31.48 Bn | 1.53 Bn | - |
| 4 | Medline | 32.66 Bn | 30.42 Bn | 1.84 Bn | 10.66% |
| 5 | Resmed | 29.13 Bn | 27.47 Bn | 890.98 Mn | 10.81% |
| 6 | West Pharmaceutical Services | 23.50 Bn | 23.06 Bn | 329.20 Mn | 13.80% |
| 7 | Solventum | 13.88 Bn | 13.32 Bn | 1.10 Bn | -3.04% |
| 8 | Cooper Companies | 13.84 Bn | 13.70 Bn | 735.40 Mn | 7.90% |
| 9 | Align Technology | 12.13 Bn | 11.07 Bn | 736.59 Mn | 6.21% |
| 10 | Nephros | 36.49 Mn | 32.47 Mn | 2.99 Mn | 6.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.87% |
| Dec 31, 2025 | 22.20% |
| Sep 30, 2025 | 35.42% |
| Jun 30, 2025 | 35.89% |
| Mar 31, 2025 | 38.47% |
| Dec 31, 2024 | 18.93% |
| Sep 30, 2024 | -5.99% |
| Jun 30, 2024 | -8.27% |
| Mar 31, 2024 | -4.73% |
| Dec 31, 2023 | 27.21% |
| Sep 30, 2023 | 55.33% |
| Jun 30, 2023 | 24.39% |
| Mar 31, 2023 | 71.24% |
| Dec 31, 2022 | -5.71% |
| Sep 30, 2022 | -6.56% |
| Jun 30, 2022 | 25.77% |
| Mar 31, 2022 | -21.09% |
| Dec 31, 2021 | 16.24% |
| Sep 30, 2021 | 21.55% |
| Jun 30, 2021 | 43.69% |